FIG. 5.
Linearities of RealTime HCV (A), the bDNA assay (B), and CAP/CTM (C), as assessed with five threefold serial dilutions of clinical specimens representing genotypes (GTs) 1 to 5. The expected and the observed HCV RNA concentrations are shown on the basis of known HCV RNA concentrations, as assessed by RealTime HCV.